Reviews and advises the Board regarding budgets, audits, investment policies and major expenditures. This committee has liaison responsibilities between operations and governance.
| Committee | Term Ending |
|---|---|
| Henry Tazelaar, M.D., Chair | 2019 |
| John A. Hart, M.D., Treasurer | 2019 |
| Eyas M. Hattab, M.D., MBA | 2019 |
| Cain McClary, M.D. | 2019 |
| Zaibo Li, M.D., Ph.D., MBA | 2020 |
| Aleodor (Doru) A. Andea, M.D., MBA | 2021 |
| Ryanne Brown, M.D., MBA | 2021 |
| Wendy L. Frankel, M.D. (Ex-Officio) | |
| David B. Kaminsky, M.D. (Ex-Officio) | |
| Travis Newman (Director of Finance) | |
| Paul Lewin (Chief of Business Development) |
